Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Xanthine oxidoreductase-IN-3 is an orally active xanthine oxidoreductase (XOR) inhibitor (IC50: 26.3 nM).Xanthine oxidoreductase-IN-3 can be used in acute hyperuricemia studies.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 258.00 | |
5 mg | In stock | $ 642.00 | |
10 mg | In stock | $ 913.00 | |
25 mg | In stock | $ 1,370.00 | |
50 mg | In stock | $ 1,850.00 | |
100 mg | In stock | $ 2,500.00 | |
500 mg | In stock | $ 4,900.00 |
Description | Xanthine oxidoreductase-IN-3 is an orally active xanthine oxidoreductase (XOR) inhibitor (IC50: 26.3 nM).Xanthine oxidoreductase-IN-3 can be used in acute hyperuricemia studies. |
Targets&IC50 | XOR:26.3 nM |
In vivo | Xanthine oxidoreductase-IN-3 (compound IIIa) (5 mg/kg; oral) was shown to reduce uric acid in acute hyperuricemia mice 3 h after administration.[1] |
Molecular Weight | 299.72 |
Formula | C14H10ClN5O |
CAS No. | 651769-78-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Xanthine oxidoreductase-IN-3 651769-78-7 Metabolism Xanthine Oxidase inhibitor inhibit